GSA CAPITAL PARTNERS LLP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 226 filers reported holding IMMUNOMEDICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$308,000
+4.8%
14,568
-31.3%
0.04%
+9.1%
Q2 2019$294,000
+374.2%
21,200
+58.0%
0.03%
+560.0%
Q4 2013$62,000
-82.9%
13,419
-77.1%
0.01%
-82.8%
Q3 2013$362,000
-75.4%
58,538
-78.4%
0.03%
-83.3%
Q2 2013$1,471,000270,4900.17%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders